A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA)

Occupational and Environmental Medicine

Volumn 72, Issue 5, 2015, Pages 373-380

  Steenland, Kyle ^a   Zhao, Liping ^a   Winquist, Andrea ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DRINKING WATER; PERFLUOROOCTANOIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; WATER POLLUTANT;

ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; BLADDER CANCER; BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HYPOTHYROIDISM; INCIDENCE; LIVER DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROSTATE CANCER; RHEUMATOID ARTHRITIS; ULCERATIVE COLITIS; ADULT; ADVERSE EFFECTS; AGED; BLOOD; CHEMICALLY INDUCED; HYPERCHOLESTEROLEMIA; LIVER DISEASES; MIDDLE AGED; PROSTATE TUMOR; WATER POLLUTANT; YOUNG ADULT;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CAPRYLATES; COHORT STUDIES; COLITIS, ULCERATIVE; FLUOROCARBONS; HUMANS; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; INCIDENCE; LIVER DISEASES; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PROSTATIC NEOPLASMS; WATER POLLUTANTS, CHEMICAL; YOUNG ADULT;

EID: 84928103004     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oemed-2014-102364     Document Type: Article

References (30)

1. Lau C, Anitole K, Hodes C, et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007;99:366-94.
2. Bartell SM, Calafat AM, Lyu C, et al. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect 2010;118:222-8.
3. Brede E, Wilhelm M, Goen T, et al. Two-year follow-up biomonitoring pilot study of residents' and controls' PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int J Hyg Environ Health 2010;213:217-23.
4. Olsen GW, Burris JM, Ehresman DJ, et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007;115:1298-305.
5. Woskie S, Gore R, Steenland K. Retrospective exposure assessment of perfluorooctanoic acid (PFOA) serum concentrations at a fluoropolymer manufacturing plant. Ann Hyg 2012;56:1025-37.
6. Shin HM, Vieira VM, Ryan PB, et al. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ Health Perspect 2011;119:1760-5.
7. Strynar MJ, Lindstrom AB. Perfluorinated compounds in house dust from Ohio and North Carolina, USA. Environ Sci Technol 2008;42:3751-6.
8. Fromme H, Tittlemier SA, Volkel W, et al. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int J Hyg Environ Health 2009;212:239-70.
9. Kato K, Wong LY, Jia LT, et al. Trends in exposure to polyfluoroalkyl chemicals in the U. S. Population: 1999-2008. Environ Sci Technol 2011;45:8037-45.
10. Kennedy GL Jr, Butenhoff JL, Olsen GW, et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol 2004;34:351-84.
11. Steenland K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 2010;118:1100-8.
12. Steenland K, Zhao L, Winquist A, et al. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect 2013;121:900-5.
13. Winquist A, Steenland K. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts. Epidemiology 2014;25:255-64.
14. Steenland K, Tinker S, Frisbee S, et al. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am J Epidemiol 2009;170:1268-78.
15. Winquist A, Steenland K. Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts. Environ Health Perspect 2014;122:1299-305.
16. Steenland K, Woskie S. Mortality patterns among workers exposed to PFOA. Am J Epidemiol 2012;176:909-17.
17. Barry V, Winquist A, Steenland K. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect 2013;121:1313-18.
18. Vieira VM, Hoffman K, Shin HM, et al. Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis. Environ Health Perspect 2013;121:318-23.
19. Eriksen KT, Sorensen M, McLaughlin JK, et al. Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst 2009;101:605-9.
20. Lundin JI, Alexander BH, Olsen GW, et al. Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 2009;20:921-8.
21. Darrow LA, Stein CR, Steenland K. Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010. Environ Health Perspect 2013;121:1207-13.
22. Winquist A, Lally C, Shin HM, et al. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers. Environ Health Perspect 2013;121:893-9.
23. Raleigh KK, Alexander BH, Olsen GW, et al. Mortality and cancer incidence in ammonium perfluorooctanoate production workers. Occup Environ Med 2014;71:500-6.
24. Leonard RC, Kreckmann KH, Sakr CJ, et al. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 2008;18:15-22.
25. Steenland K, Jin C, MacNeil J, et al. Predictors of PFOA levels in a community surrounding a chemical plant. Environ Health Perspect 2009;117:1083-8.
26. DeWitt JC, Peden-Adams MM, Keller JM, et al. Immunotoxicity of perfluorinated compounds: recent developments. Toxicol Pathol 2012;40:300-11.
27. Gallo V, Leonardi G, Genser B, et al. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure. Environ Health Perspect 2012;120:655-60.
28. MacNeil J, Steenland K, Shankar A, et al. A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). Environ Res 2009;109:997-1003.
29. Karnes C, Winquist A, Steenland K. Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid. Environ Res 2014;128:78-83.
30. Steenland K, Seals R, Klein M, et al. Risk estimation with epidemiologic data when response attenuates at high-exposure levels. Environ Health Perspect 2011;119:831-7.